QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
44.84
+1.81 (4.21%)
Dec 20, 2024, 4:00 PM EST - Market closed
QuidelOrtho Revenue
QuidelOrtho had revenue of $727.10M in the quarter ending September 29, 2024, a decrease of -2.27%. This brings the company's revenue in the last twelve months to $2.82B, down -9.74% year-over-year. In the year 2023, QuidelOrtho had annual revenue of $3.00B, down -8.21%.
Revenue (ttm)
$2.82B
Revenue Growth
-9.74%
P/S Ratio
1.07
Revenue / Employee
$396,859
Employees
7,100
Market Cap
3.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
| Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
| Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
| Jan 3, 2021 | 1.66B | 1.13B | 210.66% |
| Dec 31, 2019 | 534.89M | 12.61M | 2.41% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BrightSpring Health Services | 10.59B |
| Amedisys | 2.32B |
| ACADIA Pharmaceuticals | 929.24M |
| Warby Parker | 742.53M |
| iRhythm Technologies | 560.03M |
| Amicus Therapeutics | 493.67M |
| Zai Lab | 355.75M |
| Merus | 35.93M |
QDEL News
- 11 days ago - QuidelOrtho Announces Appointment of Two Independent Directors to its Board - Business Wire
- 4 weeks ago - Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted - Benzinga
- 4 weeks ago - Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 4 weeks ago - QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group - Business Wire
- 4 weeks ago - QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group - Business Wire
- 5 weeks ago - Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm - PRNewsWire
- 5 weeks ago - Top 4 Health Care Stocks That May Plunge This Quarter - Benzinga
- 6 weeks ago - QuidelOrtho Corporation (QDEL) Q3 2024 Earnings Call Transcript - Seeking Alpha